RELNEU Trademark

Trademark Overview


On Wednesday, April 9, 2008, a trademark application was filed for RELNEU with the United States Patent and Trademark Office. The USPTO has given the RELNEU trademark a serial number of 77444020. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 14, 2009. This trademark is owned by Pfizer Inc.. The RELNEU trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and pharmaceutical preparations that accelerate and enhance bone healing
relneu

General Information


Serial Number77444020
Word MarkRELNEU
Filing DateWednesday, April 9, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 14, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2008

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and pharmaceutical preparations that accelerate and enhance bone healing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 14, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, December 14, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 14, 2009ABANDONMENT - NO USE STATEMENT FILED
Monday, May 4, 2009EXTENSION 1 GRANTED
Monday, May 4, 2009EXTENSION 1 FILED
Monday, May 4, 2009TEAS EXTENSION RECEIVED
Tuesday, November 11, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 19, 2008PUBLISHED FOR OPPOSITION
Wednesday, July 30, 2008NOTICE OF PUBLICATION
Tuesday, July 15, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 15, 2008ASSIGNED TO LIE
Tuesday, July 15, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 15, 2008ASSIGNED TO EXAMINER
Monday, April 14, 2008NEW APPLICATION ENTERED IN TRAM